Sodium Nitroprusside Injection, Solution
Product Images NDC 75907-290

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 75907-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sleeve (Sleeve)

Sodium Nitroprusside injection solution label for infusion, showing drug name, and instructions including protection from light. The label includes dosage fields, expiration, dilution, and timing information blanks. It is marked for intravenous infusion and indicates it should be discarded 24 hours after dilution. The label is black with white text and is produced by Dr. Reddy's Laboratories Inc.*

FDA Label Image

Sleevecarton (Sleevecarton)

Packaging label for Sodium Nitroprusside injection solution (infusion) highlighting the presence of a light protective sleeve. The label instructs that the infusion solution must be protected from light by covering it with the enclosed light protective sleeve or other opaque material. The label includes the brand mark PREMIER ProRx and is associated with Dr.Reddy's Laboratories Inc.*

FDA Label Image

Carton (Carton)

Sodium Nitroprusside Injection 50 mg/2 mL Vial (25 mg/mL) carton label from Dr. Reddy's Laboratories Inc. The label indicates a 2 mL single-dose vial with instructions for intravenous infusion only, dilution requirements, and monitoring blood pressure during administration. It includes storage instructions, light protection warnings, and dosage dilution details with a barcode and NDC 75907-290-11.*

FDA Label Image

Metablosiumfig (Metablosium Fig)

An illustration titled 'Metabolism of Sodium Nitroprusside' depicting biochemical pathways. It shows the transformation of sodium nitroprusside involving active cytochromes, cyanide, cyanmethHb, metHb, thiosulfate, and thiocyanate, with renal excretion noted. The diagram includes enzymatic action by rhodanase and exchanges between hemoglobin forms.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of sodium nitroprusside, showing an iron (Fe) center coordinated to cyanide (CN) groups, nitric oxide (ON), sodium ions (Na+), and water molecules (H2O).*

FDA Label Image

Vial (Vial)

Label for Sodium Nitroprusside Injection, 50 mg/2 mL vial (25 mg/mL) for intravenous infusion. The label indicates a 2 mL single-dose vial, prescription use only, and includes the NDC 75907-290-11. The product is labeled by Dr. Reddy's Laboratories Inc. with storage instructions and a barcode visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.